Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Milja Belik, Pinja Jalkanen, Rickard Lundberg, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 296
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 7, pp. 838-849
Open Access | Times Cited: 37
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, et al.
EBioMedicine (2023) Vol. 88, pp. 104435-104435
Open Access | Times Cited: 28
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
Flor M. Muñoz, Christine M. Posavad, Barbra A. Richardson, et al.
Vaccine (2023) Vol. 41, Iss. 36, pp. 5296-5303
Open Access | Times Cited: 24
Differences between the course of SARS-CoV-2 infections in the periods of the Delta and Omicron variants dominance in Poland
Krystyna Dobrowolska, Michał Brzdęk, Dorota Zarębska‐Michaluk, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 22
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
Birte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2184-2197
Open Access | Times Cited: 13
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
Arttu Reinholm, Sari Maljanen, Pinja Jalkanen, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
Dorota Zarębska‐Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 20
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 67-73
Open Access | Times Cited: 18
Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression
Anaïs Corma‐Gómez, Marta Fernández‐Fuertes, Laura Viñuela, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 10
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Alina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2
Kuo-Ming Lee, Syh‐Jae Lin, Chung-Jung Wu, et al.
Biomedical Journal (2023) Vol. 46, Iss. 1, pp. 70-80
Open Access | Times Cited: 9
Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2
Philipp Girl, Heiner von Buttlar, Enrico Mantel, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 515-515
Open Access | Times Cited: 2
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
Real-World Effectiveness of a Booster Dose of the COVID-19 Vaccines among Japanese University Students
Shunsuke Miyauchi, Toru Hiyama, Yukiko Nakano, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1283-1283
Open Access | Times Cited: 13
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 10, pp. e1010882-e1010882
Open Access | Times Cited: 13
The importance of booster vaccination in the context of Omicron wave
Zichun Wei, Jiarui He, Conghui Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up
Antti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Nanomedicine approaches against SARS-CoV-2 and variants
Han Zhang, Yanbin Liu, Zhuang Liu
Journal of Controlled Release (2023) Vol. 365, pp. 101-111
Closed Access | Times Cited: 5
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection
Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, et al.
Vaccine (2022) Vol. 40, Iss. 40, pp. 5752-5756
Open Access | Times Cited: 9
210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1703-1703
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top